Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers
Key facts
- Who runs it
- University Hospital, Tours
- Where
- France4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 9 Apr 2026
- Expected to end
- Apr 2036
- Type of study
- Observational
- Record updated
- 6 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age ≥ 18 years
- Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment
- Obtaining non-opposition
Who cannot take part
- Intracerebral hemorrhage secondary to another identified condition, including:; vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.); intracranial tumor; hemorrhagic transformation of a cerebral infarction; recent head trauma
- First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting)
- Patient under legal protection
- Patient under guardianship or conservatorship
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.
Read full original descriptionShow less
The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.
The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 May 2026